Inhibition by doxorubicin of human immuno-deficiency virus (HIV) infection and replication in vitro.
D000386:AIDS-Related Complex / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D009189:Avian Myeloblastosis Virus / Q000187:drug effects; D017977:Deltaretrovirus / Q000187:drug effects*; D004317:Doxorubicin / Q000494:pharmacology* / Q000627:therapeutic use; D007940:Leukemia L5178; D018894:Reverse Transcriptase Inhibitors; D014779:Virus Replication / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D018894:Reverse Transcriptase Inhibitors; D004317:Doxorubicin